Follow The Filings

RCKT position history

The shares of Rocket Pharmaceuticals (RCKT) that Opaleye Management Inc. reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2025 Q4: 1,910,000 shares, $6.7M, 0.88% of portfolio, New
  2. 2026 Q1: 955,000 shares, $3.4M, 0.45% of portfolio, Reduce −50.0%
  3. 2026 Q2: 1,000,000 shares, $3.4M, 0.31% of portfolio, Add +4.7%
Holdings date Value % of holdings Shares Filing date All 13F holders